CVE-2023-22946

Apache Spark proxy-user privilege escalation from malicious configuration class

Description

In Apache Spark versions prior to 3.4.0, applications using spark-submit can specify a 'proxy-user' to run as, limiting privileges. The application can execute code with the privileges of the submitting user, however, by providing malicious configuration-related classes on the classpath. This affects architectures relying on proxy-user, for example those using Apache Livy to manage submitted applications. Update to Apache Spark 3.4.0 or later, and ensure that spark.submit.proxyUser.allowCustomClasspathInClusterMode is set to its default of "false", and is not overridden by submitted applications.

Category

6.4
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.37%
Vendor Advisory apache.org
Affected: Apache Software Foundation Apache Spark
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-22946?
CVE-2023-22946 has been scored as a medium severity vulnerability.
How to fix CVE-2023-22946?
To fix CVE-2023-22946, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-22946 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-22946 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-22946?
CVE-2023-22946 affects Apache Software Foundation Apache Spark.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.